Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NLRP3 inflammasome is an intracellular multiprotein complex that plays a critical role in the innate immune system. It acts as a sensor for pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), triggering the activation of caspase-1 and the subsequent release of pro-inflammatory cytokines IL-1β and IL-18. Dysregulation of the NLRP3 inflammasome is implicated in various chronic inflammatory diseases, making it a promising therapeutic target.
Inhibition of NLRP3 inflammasome assembly and activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleotide-binding domain-like receptor protein 3 inflammasome (NLRP3).